- Home
- RAYA vs SLGL Comparison
RAYA vs SLGL Comparison
Compare RAYA & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- SLGL
- Stock Information
- Founded
- RAYA 2019
- SLGL 1997
- Country
- RAYA China
- SLGL Israel
- Employees
- RAYA N/A
- SLGL N/A
- Industry
- RAYA Metal Fabrications
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- RAYA Consumer Discretionary
- SLGL Health Care
- Exchange
- RAYA Nasdaq
- SLGL Nasdaq
- Market Cap
- RAYA 103.6M
- SLGL 19.3M
- IPO Year
- RAYA 2022
- SLGL 2018
- Fundamental
- Price
- RAYA $2.64
- SLGL $8.54
- Analyst Decision
- RAYA
- SLGL Buy
- Analyst Count
- RAYA 0
- SLGL 1
- Target Price
- RAYA N/A
- SLGL $40.00
- AVG Volume (30 Days)
- RAYA 548.6K
- SLGL 25.5K
- Earning Date
- RAYA 01-01-0001
- SLGL 08-15-2025
- Dividend Yield
- RAYA N/A
- SLGL N/A
- EPS Growth
- RAYA N/A
- SLGL N/A
- EPS
- RAYA N/A
- SLGL N/A
- Revenue
- RAYA $30,300,360.00
- SLGL $12,103,000.00
- Revenue This Year
- RAYA $20.95
- SLGL N/A
- Revenue Next Year
- RAYA N/A
- SLGL $31.17
- P/E Ratio
- RAYA N/A
- SLGL N/A
- Revenue Growth
- RAYA 49.10
- SLGL 603.66
- 52 Week Low
- RAYA $0.56
- SLGL $3.34
- 52 Week High
- RAYA $3.14
- SLGL $16.50
- Technical
- Relative Strength Index (RSI)
- RAYA 60.08
- SLGL 63.80
- Support Level
- RAYA $2.31
- SLGL $6.96
- Resistance Level
- RAYA $2.99
- SLGL $7.48
- Average True Range (ATR)
- RAYA 0.42
- SLGL 0.26
- MACD
- RAYA 0.01
- SLGL 0.07
- Stochastic Oscillator
- RAYA 63.95
- SLGL 100.00
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.